Suven Pharma Acquires 56% Stake in US Firm NJ Bio Inc for USD 64.4 Million
December 7, 2024 16:20
Suven Pharmaceuticals will acquire a controlling stake in US-based NJ Bio Inc for USD 64.4 million, expanding its presence in the ADC/XDC segment. The transaction is expected to close before the...